Literature DB >> 33508948

β2M Signals Monocytes Through Non-Canonical TGFβ Receptor Signal Transduction.

Zachary T Hilt1,2, Preeti Maurya1, Laura Tesoro1,3, Daphne N Pariser1, Sara K Ture1, Simon J Cleary4, Mark R Looney4, Kathleen E McGrath5, Craig N Morrell1,6.   

Abstract

RATIONALE: Circulating monocytes can have proinflammatory or proreparative phenotypes. The endogenous signaling molecules and pathways that regulate monocyte polarization in vivo are poorly understood. We have shown that platelet-derived β2M (β-2 microglobulin) and TGF-β (transforming growth factor β) have opposing effects on monocytes by inducing inflammatory and reparative phenotypes, respectively, but each bind and signal through the same receptor. We now define the signaling pathways involved.
OBJECTIVE: To determine the molecular mechanisms and signal transduction pathways by which β2M and TGF-β regulate monocyte responses both in vitro and in vivo. METHODS AND
RESULTS: Wild-type- (WT) and platelet-specific β2M knockout mice were treated intravenously with either β2M or TGF-β to increase plasma concentrations to those in cardiovascular diseases. Elevated plasma β2M increased proinflammatory monocytes, while increased plasma TGFβ increased proreparative monocytes. TGF-βR (TGF-β receptor) inhibition blunted monocyte responses to both β2M and TGF-β in vivo. Using imaging flow cytometry, we found that β2M decreased monocyte SMAD2/3 nuclear localization, while TGF-β promoted SMAD nuclear translocation but decreased noncanonical/inflammatory (JNK [jun kinase] and NF-κB [nuclear factor-κB] nuclear localization). This was confirmed in vitro using both imaging flow cytometry and immunoblots. β2M, but not TGF-β, promoted ubiquitination of SMAD3 and SMAD4, that inhibited their nuclear trafficking. Inhibition of ubiquitin ligase activity blocked noncanonical SMAD-independent monocyte signaling and skewed monocytes towards a proreparative monocyte response.
CONCLUSIONS: Our findings indicate that elevated plasma β2M and TGF-β dichotomously polarize monocytes. Furthermore, these immune molecules share a common receptor but induce SMAD-dependent canonical signaling (TGF-β) versus noncanonical SMAD-independent signaling (β2M) in a ubiquitin ligase dependent manner. This work has broad implications as β2M is increased in several inflammatory conditions, while TGF-β is increased in fibrotic diseases. Graphic Abstract: A graphic abstract is available for this article.

Entities:  

Keywords:  cytokines; inflammation; monocytes; platelets; transforming growth factors

Mesh:

Substances:

Year:  2021        PMID: 33508948      PMCID: PMC8319031          DOI: 10.1161/CIRCRESAHA.120.317119

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  39 in total

1.  Beta2-microglobulin as a potential initiator of inflammatory responses.

Authors:  Jin Xie; Qing Yi
Journal:  Trends Immunol       Date:  2003-05       Impact factor: 16.687

Review 2.  Regulation of TGF-beta family signaling by E3 ubiquitin ligases.

Authors:  Yasumichi Inoue; Takeshi Imamura
Journal:  Cancer Sci       Date:  2008-09-18       Impact factor: 6.716

3.  Peptide and small molecule inhibitors of HECT-type ubiquitin ligases.

Authors:  Thomas Mund; Michael J Lewis; Sarah Maslen; Hugh R Pelham
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

4.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

5.  Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin.

Authors:  D J Grainger; L Wakefield; H W Bethell; R W Farndale; J C Metcalfe
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

Review 6.  Monocyte-mediated defense against microbial pathogens.

Authors:  Natalya V Serbina; Ting Jia; Tobias M Hohl; Eric G Pamer
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

7.  Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptor-associated factor 6-mediated activation of c-Jun NH2-terminal kinase.

Authors:  Christopher Hull; Graeme McLean; Fred Wong; Patrick J Duriez; Aly Karsan
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

8.  Patrolling monocytes control tumor metastasis to the lung.

Authors:  Richard N Hanna; Caglar Cekic; Duygu Sag; Robert Tacke; Graham D Thomas; Heba Nowyhed; Erica Herrley; Nicole Rasquinha; Sara McArdle; Runpei Wu; Esther Peluso; Daniel Metzger; Hiroshi Ichinose; Iftach Shaked; Grzegorz Chodaczek; Subhra K Biswas; Catherine C Hedrick
Journal:  Science       Date:  2015-10-22       Impact factor: 47.728

Review 9.  Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination.

Authors:  Feng Xie; Zhengkui Zhang; Hans van Dam; Long Zhang; Fangfang Zhou
Journal:  Cells       Date:  2014-10-15       Impact factor: 6.600

10.  NF-κB pathways are involved in M1 polarization of RAW 264.7 macrophage by polyporus polysaccharide in the tumor microenvironment.

Authors:  Chun-Ping Liu; Xian Zhang; Qing-Long Tan; Wen-Xing Xu; Chang-Yuan Zhou; Min Luo; Xiong Li; Run-Yue Huang; Xing Zeng
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

View more
  2 in total

1.  A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease.

Authors:  Ahmed M I Elfiky; Ishtu L Hageman; Marte A J Becker; Jan Verhoeff; Andrew Y F Li Yim; Vincent W Joustra; Lieven Mulders; Ivan Fung; Inmaculada Rioja; Rab K Prinjha; Nicholas N Smithers; Rebecca C Furze; Palwinder K Mander; Matthew J Bell; Christianne J Buskens; Geert R D'Haens; Manon E Wildenberg; Wouter J de Jonge
Journal:  Cells       Date:  2022-09-12       Impact factor: 7.666

Review 2.  The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.

Authors:  Yu-Yao He; Hai-Feng Zhou; Lu Chen; Yan-Ting Wang; Wan-Li Xie; Zhen-Zhen Xu; Yue Xiong; Yi-Qi Feng; Guo-Yang Liu; Xia Li; Jie Liu; Qing-Ping Wu
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.